Physician profile
Daniel Refai
NPI 1912092800
$1,218,052.40
in general payments reported to CMS, 2019-2025
12 companies · $191K in 2025
The $191K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130K · 2020: $110K · 2021: $205K · 2022: $244K · 2023: $182K · 2024: $158K · 2025: $191K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $359K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $84K · Royalty Or License: $47K · Travel and Lodging: $32K · Food and Beverage: $8,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $359,377.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $83,950.00 |
| Royalty Or License | $46,778.89 |
| Travel and Lodging | $31,529.51 |
| Food and Beverage | $8,419.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $753,845.33 | 2019-2025 | Everest Spinal System, Capri Corpectomy Cage System, Core |
| Medical Device Business Services, INC. | $132,071.45 | 2019-2025 | Expedium, Conduit, Symphony |
| Medtronic, INC. | $124,838.24 | 2021-2025 | |
| Globus Medical, INC. | $96,154.70 | 2019-2025 | Hedron P, Quartex, Hedron |
| Medtronic USA, INC. | $49,502.28 | 2019-2020 | |
| Vb Spine LLC | $33,349.22 | 2025 | Yukon Oct Spinal System, Cascadia Interbody System, Xia 3 |
| Arthrex, INC. | $26,672.05 | 2025 | |
| Depuy Synthes Sales INC. | $952.09 | 2019-2025 | Teligen, Velys, Trialtis |
| United Orthopedics LLC | $495.00 | 2025 | |
| Spineart USA INC | $130.00 | 2025 | |
| Aesculap Implant Systems, LLC | $42.04 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,458,693.43 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Refai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.